Adenosine is a signaling nucleoside that impacts cellular physiology by binding G-protein coupled receptors on the surface of target cells. There is mounting evidence that adenosine signaling plays an important role in lung inflammation and damage characteristic of asthma, yet the signaling mechanisms and cell types involved are not well understood. Nor is it known what role adenosine signaling plays in lung development. We have taken a genetic approach to study the role of adenosine signaling in lung development and the onset of inflammatory responses characteristic of asthma. To this end, we generated mice deficient in the purine catabolic enzyme adenosine deaminase (ADA). ADA is responsible for controlling the levels of adenosine in tissues and cells, and ADA deficient mice consequently exhibit elevated levels of adenosine in many tissues, including the lung. ADA deficient mice develop respiratory disease early in life, characterized by a significant lung eosinophilia followed by smooth muscle thickening, epithelial damage, and death of the animal by three weeks of age. This inflammation and damage is dependent on elevated levels of adenosine in that the condition is rapidly reversed following the removal of adenosine by ADA enzyme therapy. These animals will provide an opportunity to study the role of adenosine signaling in asthma and to investigate the influence of environmental factors in this genetic model. Furthermore, recent findings suggest that the lungs of ADA deficient mice are damaged prenatally in association with elevated adenosine levels, leading to the hypothesis that aberrant adenosine signaling in the prenatal and neonatal lung of ADA deficient mice predisposes the lung to inflammation and damage.
Four specific aims are designed to test this hypothesis: 1. Determine the nature and ontogeny of the lung inflammation and damage seen in prenatal and neonatal ADA deficient mice. 2. Determine if the changes in prenatal and neonatal ADA deficient lungs are dependent on adenosine. 3. Assess the cell type specific expression of adenosine receptors in normal and ADA deficient prenatal and neonatal lungs. 4. Evaluate acute and long-term changes of airway function in ADA deficient mice as well as ADA deficient mice exposed to environmental challenges.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL061888-02
Application #
6056579
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Project Start
1998-09-30
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Houston
State
TX
Country
United States
Zip Code
77225
Colasurdo, Giuseppe N; Fullmer, Jason J; Elidemir, Okan et al. (2006) Respiratory syncytial virus infection in a murine model of cystic fibrosis. J Med Virol 78:651-8
Stark, James M; Khan, Amir M; Chiappetta, Constance L et al. (2005) Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection. J Infect Dis 191:387-95
Banerjee, Suman K; Young, Hays W J; Barczak, Andrea et al. (2004) Abnormal alveolar development associated with elevated adenine nucleosides. Am J Respir Cell Mol Biol 30:38-50
Blackburn, Michael R; Lee, Chun G; Young, Hays W J et al. (2003) Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112:332-44
Zhong, Hongyan; Shlykov, Sergiy G; Molina, Jose G et al. (2003) Activation of murine lung mast cells by the adenosine A3 receptor. J Immunol 171:338-45
Banerjee, Suman K; Young, Hays W J; Volmer, Jonathan B et al. (2002) Gene expression profiling in inflammatory airway disease associated with elevated adenosine. Am J Physiol Lung Cell Mol Physiol 282:L169-82
Zhong, H; Chunn, J L; Volmer, J B et al. (2001) Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice. J Pharmacol Exp Ther 298:433-40
Chunn, J L; Young, H W; Banerjee, S K et al. (2001) Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167:4676-85
Apasov, S G; Blackburn, M R; Kellems, R E et al. (2001) Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest 108:131-41
Blackburn, M R; Aldrich, M; Volmer, J B et al. (2000) The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalities. J Biol Chem 275:32114-21

Showing the most recent 10 out of 12 publications